Rabbit F(ab')2 Anti-Rat IgG(H+L), Human ads-FITC

Cat. No.
6135-02  
Size
0.5 mg  
Price (USD)
$130.00 
Specificity Reacts with the heavy and light chains of rat IgG and the light chains of rat IgM
Source Pepsin digest of Rabbit Anti-Rat IgG(H+L), Human ads (SB Cat. No. 6185)
Cross Adsorption Human immunoglobulins and pooled sera; may react with immunoglobulins from other species and the light chains of other rat immunoglobulins
Isotype Rabbit F(ab')2 IgG
Isotype Control Rabbit F(ab')2 IgG-FITC
Format/Conjugate FITC (Fluorescein)
Buffer Formulation Phosphate buffered saline containing 0.1% sodium azide
Concentration 0.5 mg/mL
Volume 1.0 mL
Storage & Handling 2-8°C; Avoid exposure to light
Please refer to product specific SDS
Applications
Quality tested applications for relevant formats include -
ELISA
FLISA
Other referenced applications for relevant formats include -
Flow Cytometry 1-3
Immunocytochemistry 4
Recommended Dilutions Please refer to product specific Technical Bulletin
RRID AB_2796191
  • FLISA plate was coated with purified rat IgG and IgM. Immunoglobulins were detected with serially diluted Rabbit F(ab')2 Anti-Rat IgG(H+L), Human ads-FITC (SB Cat. No. 6135-02).

FLISA plate was coated with purified rat IgG and IgM. Immunoglobulins were detected with serially diluted Rabbit F(ab')2 Anti-Rat IgG(H+L), Human ads-FITC (SB Cat. No. 6135-02).
 
Related Products (9)
References
1. Moreno J, Nieto J, Chamizo C, González F, Blanco F, Barker DC, et al. The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy. Vet Immunol Immunopathol. 1999;71:181-95. (FC)
2. Guarga JL, Moreno J, Lucientes J, Gracia MJ, Peribáñez MA, Castillo JA. Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis. Vet Immunol Immunopathol. 2002;88:13-20. (FC)
3. Beenhouwer DO, Yoo EM, Lai C, Rocha MA, Morrison SL. Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. Infect Immun. 2007;75:1424-35. (FC)
4. Tai X, Yashiro Y, Abe R, Toyooka K, Wood CR, Morris J, et al. A role for CD9 molecules in T cell activation. J Exp Med. 1996;184:753-8. (ICC)